Mason & Associates (California)’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$168K Hold
33,165
0.04% 120
2025
Q1
$175K Buy
+33,165
New +$175K 0.04% 113